DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Nakamura M, Shimizu-Yoshida Y, Takii Y. et al.
Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis
J Hepatol 2005; 42: 386-392
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.